These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10882016)

  • 1. New carbamoylpiperidines as human platelet aggregation inhibitors.
    Guo Z; Zheng X; Thompson W; Dugdale M; Gollamudi R
    Bioorg Med Chem; 2000 May; 8(5):1041-58. PubMed ID: 10882016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular determinants of the platelet aggregation inhibitory activity of carbamoylpiperidines.
    Feng Z; Gollamudi R; Dillingham EO; Bond SE; Lyman BA; Purcell WP; Hill RJ; Korfmacher WA
    J Med Chem; 1992 Aug; 35(16):2952-8. PubMed ID: 1501222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of PAF-induced human platelet aggregation by antithrombotic nipecotomides.
    Herron D; Dillingham EO; Lyman BA; Zheng X; Bond SE; Salgia SR; Gollamudi R
    Prostaglandins Leukot Essent Fatty Acids; 1995 May; 52(5):309-18. PubMed ID: 7630919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enantioselective antiplatelet actions of nipecotamides.
    Gollamudi R; Feng Z; Dillingham EO; Bond SE; Han G; Salgia S
    Thromb Res; 1993 Feb; 69(4):361-7. PubMed ID: 8470057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of piperidine-3-carboxamides as human platelet aggregation inhibitors.
    Zheng X; Salgia SR; Thompson WB; Dillingham EO; Bond SE; Feng Z; Prasad KR; Gollamudi R
    J Med Chem; 1995 Jan; 38(1):180-8. PubMed ID: 7837229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of agonist-induced rise in platelet Ca2+ by antithrombotic nipecotamides.
    Gollamudi R; Dillingham EO; Bond SE
    Blood Coagul Fibrinolysis; 1994 Jun; 5(3):375-83. PubMed ID: 8075309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of platelet aggregation inhibitory activity by phenyl amides and esters of piperidinecarboxylic acids.
    de Candia M; Summo L; Carrieri A; Altomare C; Nardecchia A; Cellamare S; Carotti A
    Bioorg Med Chem; 2003 Apr; 11(7):1439-50. PubMed ID: 12628670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplatelet activity of nipecotamides in experimental thrombosis in mice.
    Lawrence WH; Howell RD; Gollamudi R
    J Pharm Sci; 1994 Feb; 83(2):222-5. PubMed ID: 8169794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereoselective inhibition of human platelet aggregation by R-138727, the active metabolite of CS-747 (prasugrel, LY640315), a novel P2Y12 receptor inhibitor.
    Hasegawa M; Sugidachi A; Ogawa T; Isobe T; Jakubowski JA; Asai F
    Thromb Haemost; 2005 Sep; 94(3):593-8. PubMed ID: 16268477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of H2-receptor antagonists on platelet function in vitro.
    Nakamura K; Kariyazono H; Shinkawa T; Yamaguchi T; Yamashita T; Ayukawa O; Moriyama Y; Yotsumoto G; Toyohira H; Taira A; Yamada K
    Hum Exp Toxicol; 1999 Aug; 18(8):487-92. PubMed ID: 10462360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New platelet aggregation inhibitors based on pyridazinone moiety.
    Costas T; Costas-Lago MC; Vila N; Besada P; Cano E; Terán C
    Eur J Med Chem; 2015 Apr; 94():113-22. PubMed ID: 25757094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and inhibitory activities on platelet aggregation of some flavonoid analogues.
    Göker H; Tunçbilek M; Leoncini G; Buzzi E; Mazzei M; Rolland Y; Ertan R
    Arzneimittelforschung; 1995 Feb; 45(2):150-5. PubMed ID: 7710437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorinated benzyloxyphenyl piperidine-4-carboxamides with dual function against thrombosis: inhibitors of factor Xa and platelet aggregation.
    de Candia M; Liantonio F; Carotti A; De Cristofaro R; Altomare C
    J Med Chem; 2009 Feb; 52(4):1018-28. PubMed ID: 19193009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New organic nitrate-containing benzyloxy isonipecotanilide derivatives with vasodilatory and anti-platelet activity.
    de Candia M; Marini E; Zaetta G; Cellamare S; Di Stilo A; Altomare CD
    Eur J Pharm Sci; 2015 May; 72():69-80. PubMed ID: 25769522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of inositol 1,4,5-trisphosphate-induced aggregation in saponin-permeabilized platelets.
    Knezevic I; Dieter JP; Le Breton GC
    J Pharmacol Exp Ther; 1992 Mar; 260(3):947-55. PubMed ID: 1545407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships between chemical structure and inhibition of epinephrine-induced human blood platelet aggregation.
    Petrusewicz J; Lasslo A; Carter-Burks G; Gollamudi R; Dillingham EO; Bond SE
    Biochim Biophys Acta; 1989 Aug; 983(2):161-6. PubMed ID: 2758055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of N6-alkyl(aryl)-2-alkyl(aryl)thioadenosines as antiplatelet agents.
    Liu G; Xu J; Chen N; Zhang S; Ding Z; Du H
    Eur J Med Chem; 2012 Jul; 53():114-23. PubMed ID: 22531380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro effects of aprosulate sodium, a novel anticoagulant, on platelet activation: possible mechanism for antiplatelet action.
    Sugidachi A; Breiter N; Ogawa T; Asai F; Koike H
    Thromb Haemost; 1996 Nov; 76(5):786-90. PubMed ID: 8950791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Piperidine derivatives as nonprostanoid IP receptor agonists 2.
    Hayashi R; Ito H; Ishigaki T; Morita Y; Miyamoto M; Isogaya M
    Bioorg Med Chem Lett; 2016 Jun; 26(12):2886-2889. PubMed ID: 27133594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antiplatelet effects of omega-aminoalkoxylxanthones.
    Lin CN; Liou SS; Lai SC; Lin HC; Ko FN; Liu HW; Teng CM
    J Pharm Pharmacol; 1995 Jul; 47(7):588-94. PubMed ID: 8568627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.